Mr. Bronfeld has served as a member of our board of directors since 2010 and as chairman of our board of directors since September 2014 and until November 2016. Mr. Bronfeld has vast experience in the management and value building of biotechnology companies. From 2010 through July 2014, he served as the chairman of the board of Protalix BioTherapeutics, Inc. (NYSE: PLX) and has been a director on its board since 2006. Mr. Bronfeld serves as chairman of the board of directors of D.N.A Biomedical Solutions Ltd. Mr. Bronfeld is also a director of several privately-held companies, including The Trendlines Group Ltd, Contipi Medical Ltd. and as chairman of the board of TransBiodiesel Ltd. Mr. Bronfeld holds a B.A in Economics from the Hebrew University of Jerusalem.